by Havas Lynx for Sanofi Genzyme Regeneron
by Burson Cohn & Wolfe for Pfizer
by Current Global and Flipside for Novartis
by Havas Lynx for Teva
by Havas Lynx for Teva
Developing an innovative product is a challenge. For true innovation the status quo genuinely needs to be disrupted, and for the better. Anyone can create something different. True innovation needs to work and it needs to work well. Our chatbot genuinely disrupted. It disrupted congress delegate engagement and it disrupted chatbot development. MaxBot is not just another chatbot; it’s not just another fluffy delegate engagement tool. No. MaxBot is the very definition of innovation, delivering incredible ROI against tough KPIs.
The Maxbot project is quirky, creative and fun and it is great to see people using different ways to engage at congress and bring some humour and humanity to the pharma world.
Jon Pike, Mearns & Pike - Communiqué 2020 winner
Entry deadline | 11 March 2022 |
Extended entry deadline | 18 March 2022 (additional fee applies) |
Judging days | May 2022 |
Awards Ceremony | 7th July 2022 |
For sponsorship opportunities:
Sales Team
sales@pmlive.com
Tel: +44 (0)1372 414200
General event enquiries:
Debbie Tuesley
dtuesley@pmlive.com
Tel: +44 (0)1372 414243
Entry and dinner booking enquiries:
Saoirse Meenaghan
Email: smeenaghan@pmlive.com
Tel: 01372 414253